Search Ontology:
ChEBI

PI(16:0/22:4(10Z,13Z,16Z,19Z))

Term ID
CHEBI:88421
Synonyms
  • 1-Hexadecanoyl-2-(10Z,13Z,16Z,19Z-docosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
  • 1-Palmitoyl-2-(10Z,13Z,16Z,19Z-docosatetraenoyl)-sn-glycero-3-phosphoinositol
  • [(2R)-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyloxy]-3-(hexadecanoyloxy)propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
  • Phosphatidylinositol(16:0/22:4)
  • Phosphatidylinositol(16:0/22:4n3)
  • Phosphatidylinositol(16:0/22:4w3)
  • Phosphatidylinositol(38:4)
  • PI(16:0/22:4)
  • PI(16:0/22:4n3)
  • PI(16:0/22:4w3)
  • PI(38:4)
  • PIno(16:0/22:4)
  • PIno(16:0/22:4n3)
  • PIno(16:0/22:4w3)
  • PIno(38:4)
Definition
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
Phenotype
Phenotype resulting from PI(16:0/22:4(10Z,13Z,16Z,19Z))
Phenotype where environments contain PI(16:0/22:4(10Z,13Z,16Z,19Z))
Phenotype modified by environments containing PI(16:0/22:4(10Z,13Z,16Z,19Z))
Human Disease Model